# Ligand Pharmaceuticals Inc: Form 8-K, filed Feb 26, 2026

- Company: [Ligand Pharmaceuticals Inc](/companies/lgnd.md) (CIK 886163)
- Form: 8-K
- Filed: 2026-02-26
- Accepted by EDGAR: Feb 26, 2026, 07:05 ET
- Period: 2026-02-26
- Accession: 0000886163-26-000003
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/886163/000088616326000003/lgnd-20260226.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/886163/000088616326000003/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/886163/000088616326000003/lgnd-20260226.htm

Filed Feb 26, 2026.
Source: SEC EDGAR, the filing index for accession 0000886163-26-000003. Last ingested by Listed: Nov 13, 2026, 16:29 ET. No prices; not investment advice.
